[{"orgOrder":0,"company":"Meta Healthcare Ltd","sponsor":"Birmingham Women's and Children's NHS Foundation Trust","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"UNITED KINGDOM","productType":"Amino Acid","year":"2024","type":"Inapplicable","leadProduct":"L-VALINE","moa":"Propionyl-CoA carboxylase beta chain, mitochondrial; Branched-chain-amino-acid aminotransferase, cytosolic; Valine--tRNA ligase","graph1":"Genetic Disease","graph2":"Undisclosed","graph3":"Meta Healthcare Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Meta Healthcare Ltd \/ Birmingham Women's and Children's NHS Foundation Trust","highestDevelopmentStatusID":"1","companyTruncated":"Meta Healthcare Ltd \/ Birmingham Women's and Children's NHS Foundation Trust"},{"orgOrder":0,"company":"University of Texas Health Science Center at San Antonio","sponsor":"National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio","pharmaFlowCategory":"DU","therapeuticArea":"Nephrology","country":"U.S.A","productType":"Amino Acid","year":"2023","type":"Inapplicable","leadProduct":"L-VALINE","moa":"Propionyl-CoA carboxylase beta chain, mitochondrial; Branched-chain-amino-acid aminotransferase, cytosolic; Valine--tRNA ligase","graph1":"Nephrology","graph2":"Phase I","graph3":"University of Texas Health Science Center at San Antonio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Nephrology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Texas Health Science Center at San Antonio \/ National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio","highestDevelopmentStatusID":"6","companyTruncated":"University of Texas Health Science Center at San Antonio \/ National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio"}]

Find Clinical Drug Pipeline Developments & Deals for Valine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Meta Healthcare Ltd

                          Country arrow
                          PREP
                          Not Confirmed

                          Meta Healthcare Ltd

                          Country arrow
                          PREP
                          Not Confirmed

                          Details : Valine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Maple Syrup Urine Disease.

                          Product Name : Undisclosed

                          Product Type : Amino Acid

                          Upfront Cash : Inapplicable

                          September 03, 2024

                          Lead Product(s) : L-VALINE

                          Therapeutic Area : Genetic Disease

                          Highest Development Status : Undisclosed

                          Sponsor : Birmingham Women's and Children's NHS Foundation Trust

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          University of Texas Health Science Center at San Antonio

                          Country arrow
                          PREP
                          Not Confirmed

                          University of Texas Health Science Center at San Antonio

                          Country arrow
                          PREP
                          Not Confirmed

                          Lead Product(s) : L-VALINE

                          Therapeutic Area : Nephrology

                          Study Phase : Phase I

                          Sponsor : National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Valine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Kidney Failure, Chronic.

                          Product Name : Undisclosed

                          Product Type : Amino Acid

                          Upfront Cash : Inapplicable

                          January 30, 2023

                          Lead Product(s) : L-VALINE

                          Therapeutic Area : Nephrology

                          Highest Development Status : Phase I

                          Sponsor : National Center for Advancing Translational Sciences | IIMS-UT Health San Antonio

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank